-
Sector Analysis
NewNew Drug Approvals and Their Contract Manufacture – 2024 Edition
This report is the 14th edition of our long-running analysis of the CMO industry, using the FDA's NDA approvals as the primary indicator of performance. New Drug Approvals and Their Contract Manufacture (formerly called "CMO Scorecard") is critical for benchmarking the performance of the contract manufacturing organization (CMO) industry and the relative performance of major CMOs. This year's edition includes a discussion of how inflation and increasing global conflict has impacted pharma manufacturers.
-
Innovation Ranking
NewInnovation Ranking – Bausch Health Companies Inc
Bausch Health Companies Inc (Bausch Health), formerly Valeant Pharmaceuticals International Inc, is engaged in the manufacturing, development, and marketing of a range of medical devices, over-the-counter products (OTC), and pharmaceutical products. Bausch Health offers products for therapy areas related to dermatology, gastroenterology, eye health, neurology, aesthetic devices, dentistry, and consumer health. It offers various generic and branded generic products. Bausch Health has administrative, research and laboratory, marketing, distribution, and warehousing facilities worldwide. The company offers products directly or indirectly in...
-
Sector Analysis
NewIntraocular Lens (IOL) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Intraocular Lens (IOL) Market Report Overview The intraocular lens (IOL) market was valued at $4.48 billion in 2023 and the market will grow at more than 2% during 2023-2033. The rising prevalence of cataracts and refractive error coupled with the increasing population around the globe has compelled governments to start initiatives toward lowering the number of patients suffering from partial or complete blindness. This, in turn, will lead to an increase in the number of eye surgeries and the use...
-
Sector Analysis
NewOphthalmic Viscoelastic Devices (OVD) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Ophthalmic Viscoelastic Devices (OVD) Market Report Overview The ophthalmic viscoelastic devices (OVD) market size was $1.2 billion in 2023. The market will grow at a CAGR of more than 2% during 2023-2033. Ophthalmic viscoelastic devices, also known as OVDs, are devices used during intraocular surgery, especially anterior segment surgery. These are the viscoelastic materials used to maintain space in the eye during surgery. Typically, OVDs are pre-packaged in a syringe and are applied using a small tube. Essential properties of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Triamcinolone Acetonide in Diabetic Macular Edema
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Triamcinolone Acetonide in Diabetic Macular Edema report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Triamcinolone Acetonide in Diabetic Macular Edema Drug Details: Triamcinolone acetonide...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pacmilimab in Testicular Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pacmilimab in Testicular Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pacmilimab in Testicular Cancer Drug Details: CX-072 is under development for...
-
Thematic Analysis
Pharma M&A Deals 2023 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in 2023 in the Pharma Sector
-
Product Insights
Glaucoma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Glaucoma Clinical Trial Report Overview A total of 1,696 glaucoma clinical trials were conducted as of January 2024. The glaucoma clinical trial report provides a comprehensive understanding of the glaucoma clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor type and the prominent sponsors associated with the trials. Key Regions ·       Asia-Pacific ·       Europe ·       North America ·       ...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Rifaximin SSD in Sickle Cell Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Rifaximin SSD in Sickle Cell Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rifaximin SSD in Sickle Cell Disease Drug Details: Rifaximin soluble...